Gilead Sciences, Inc.

GILD · Healthcare · $184.1B

After-hours $148.48+0.66%

Price

$129.6

$147.5

Jul 6, 26Oct 1, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$7.8B-0.3%

6/'26 vs prev quarter

Company Health

Market Cap$184.1B

Operating Margin-4.9%

Cash on Hand$3.2B1.7% of market cap

Free Cash Flow$13.2B7.2% of market cap

Among 19 Drug Manufacturers - General peers

LowMedianHigh

PSR6.0xmedian 3.3xPBR15.6xmedian 5.0xROE-27.6%median +22.8%